Paper I: Halle MK, Werner H, Krakstad, C, Birkeland E, Wik E, Trovik, J, Salvesen, HB: Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. Histopathology. 2012;60:516-9. The article is not available in BORA due to publisher restrictions. The published version is available at: https://doi.org/10.1111/j.1365-2559.2011.04057.xPaper II: Halle MK, Krakstad C, Engerud H, Bertelsen B, Salvesen H: Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix. Pathol Res Pract. 2014;210:774-8. The article is not available in BORA due to publisher restrictions. The published version is available at: https://doi.org/10.1016/j.prp.2014.07.002Paper III: Halle MK, Ojesina AI, Engerud H, Woie K, Tangen IL, Holst F, Hoivik E, Kusonmano K, Haldorsen IS, Vintermyr OK, Trovik J, Bertelsen BI, Salvesen HB, Krakstad C: Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. Am J Obstet Gynecol. 2017;217:432.e1-432.e17. The article is not available in BORA due to publisher restrictions. The published version is available at: https://doi.org/10.1016/j.ajog.2017.05.068Paper IV: Halle MK, Tangen IL, Berg HF, Hoivik EA, Mauland KK, Kusonmano K, Berg A, Hurtado A, Kalland KH, Øyan AM, Stefansson I, Vintermyr OK, Werner HMJ, Haldorsen IS, Trovik J, Salvesen HB, Krakstad C: HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. Br J Cancer. 2017 Nov 23. The article is not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1038/bjc.2017.422Paper V: Gilfillan S, Halle MK, Sign S, Tangen IL, Katika MR, Salvesen HB, Krakstad C, Hurtado A: FOXA1 predicts good outcome in HER2+ endometrial cancer patients by inhibiting EGFR/HER2 signaling. The article is not available in BORA.